And Along Came Tradjenta… Or, The Wacky World of Type 2 Drugs
The world of type 2 diabetes drugs is wacky indeed. While Amylin’s long-acting version of Byetta – called Bydureon and predicted by many experts to become a blockbuster – is still held up at FDA, the agency approved a new oral drug earlier this mo…
The world of type 2 diabetes drugs is wacky indeed. While Amylin’s long-acting version of Byetta – called Bydureon and predicted by many experts to become a blockbuster – is still held up at FDA, the agency approved a new oral drug earlier this mo…
SOURCE: Healthline RSS Feed – Read entire story here.
